Literature DB >> 22705569

Trigeminal nerve injury ErbB3/ErbB2 promotes mechanical hypersensitivity.

Fei Ma1, Liping Zhang, Karin N Westlund.   

Abstract

BACKGROUND: Chronic constriction injury of the trigeminal infraorbital nerve results in transient analgesia followed by whisker pad mechanical allodynia in rats. Neuregulin 1 expressed on axonal membranes binds receptor tyrosine kinase ErbB, promoting Schwann cell development and remyelination. This study investigated whether orofacial mechanical allodynia is signaled by ErbB3-ErbB2 heterodimers in injured nerves.
METHODS: Whisker pad mechanical allodynia (von Frey stimuli) was quantified in wild type rats and in transgenic rats with Sleeping Beauty transposon mutation for neuregulin 1 transgene. Pain-related behavior was retested after intraperitoneal injection of the ErbB2 inhibitor Lapatinib, an agent shown by others to reduce breast cancer pain. Infraorbital nerve injury was evaluated histologically with myelin and neuronal biomarkers. ErbB3 changes over time were measured with western blots.
RESULTS: Whisker pad mechanical hypersensitivity began in week 2 in wild type rats (3.11 ± 5.93 g vs. 18.72 ± 0.00 g after sham surgery, n = 9, P < 0.001), indicating trigeminal neuropathic pain, but was not evident in transgenic rats (odds ratio: 1.12, 95% confidence interval: 0.38-3.35). Initiation of statistically significant mechanohypersensitivity was delayed until week 6 after surgery in transgenic rats (3.44 ± 4.60 g vs. 18.72 ± 0.00 g, n = 4, P < 0.001). Mechanical allodynia, which persisted 8 weeks in wild type rats was alleviated by Lapatinib (15 ± 3.89 g vs. 2.45 ± 1.13 g, n = 6, P < 0.001). Infraorbital nerve damage was verified histologically. Statistically significant ErbB3 increases (weeks 5 and 10) in wild type and transgenic rats (week 10) coincided with time points when mechanical hypersensitivity was present.
CONCLUSION: The Neuregulin 1-ErbB3-ErbB2 complex is a causal mechanism in nerve injury-induced trigeminal neuropathic pain. Understanding peripheral glial mechanisms after nerve injury will improve neuropathic pain treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705569      PMCID: PMC3406246          DOI: 10.1097/ALN.0b013e3182604b2b

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  32 in total

Review 1.  Neuregulin, a factor with many functions in the life of a schwann cell.

Authors:  A N Garratt; S Britsch; C Birchmeier
Journal:  Bioessays       Date:  2000-11       Impact factor: 4.345

Review 2.  Neuregulins: functions, forms, and signaling strategies.

Authors:  Douglas L Falls
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

3.  Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli.

Authors:  S B Taylor; A R Taylor; J A Markham; A M Geurts; B Z Kanaskie; J I Koenig
Journal:  Physiol Behav       Date:  2010-11-16

4.  Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration.

Authors:  S L Carroll; M L Miller; P W Frohnert; S S Kim; J A Corbett
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

5.  Mechanism of trigeminal neuralgia: an ultrastructural analysis of trigeminal root specimens obtained during microvascular decompression surgery.

Authors:  Marshall Devor; Ruth Govrin-Lippmann; Z Harry Rappaport
Journal:  J Neurosurg       Date:  2002-03       Impact factor: 5.115

Review 6.  Trigeminal neuralgia: pathology and pathogenesis.

Authors:  S Love; H B Coakham
Journal:  Brain       Date:  2001-12       Impact factor: 13.501

7.  Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve.

Authors:  B P Vos; A M Strassman; R J Maciewicz
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

8.  Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss.

Authors:  Suzhen Chen; Carlos Rio; Ru-Rong Ji; Pieter Dikkes; Richard E Coggeshall; Clifford J Woolf; Gabriel Corfas
Journal:  Nat Neurosci       Date:  2003-10-12       Impact factor: 24.884

9.  Anatomical consequences of neonatal infraorbital nerve transection upon the trigeminal ganglion and vibrissa follicle nerves in the adult rat.

Authors:  B G Klein; W E Renehan; M F Jacquin; R W Rhoades
Journal:  J Comp Neurol       Date:  1988-02-22       Impact factor: 3.215

10.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

Authors:  G J Bennett; Y K Xie
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

View more
  6 in total

1.  Persistent neuropathic pain influences persistence behavior in rats.

Authors:  Tracey C Kniffin; Robert J Danaher; Karin N Westlund; Fei Ma; Craig S Miller; Charles R Carlson
Journal:  J Oral Facial Pain Headache       Date:  2015

2.  Orofacial neuropathic pain mouse model induced by Trigeminal Inflammatory Compression (TIC) of the infraorbital nerve.

Authors:  Fei Ma; Liping Zhang; Danielle Lyons; Karin N Westlund
Journal:  Mol Brain       Date:  2012-12-28       Impact factor: 4.041

3.  Trigeminal neuralgia and genetics: A systematic review.

Authors:  Mari Aaroe Mannerak; Aslan Lashkarivand; Per Kristian Eide
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

Review 4.  Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors.

Authors:  Francis Giraud; Elisabeth Pereira; Fabrice Anizon; Pascale Moreau
Journal:  Molecules       Date:  2021-05-04       Impact factor: 4.411

Review 5.  Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models.

Authors:  Yukinori Nagakura; Shogo Nagaoka; Takahiro Kurose
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

6.  Inhibition of G protein-coupled P2Y2 receptor induced analgesia in a rat model of trigeminal neuropathic pain.

Authors:  Na Li; Zhan-ying Lu; Li-hua Yu; Geoffrey Burnstock; Xiao-ming Deng; Bei Ma
Journal:  Mol Pain       Date:  2014-03-18       Impact factor: 3.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.